Yo Shero, I'm gaining a lot of experience with these buying opportunities. I must be misspelling b-u-y or something. Oh well, if I knew what was gonna happen tomorrow I'd be at the racetrack.
So who are your candidates for the Oncolym license? How about Idec/Genentech/Hoffman LaRoche? Hoffman has the deep pockets, Genentech can sell anything, and Idec will sell anything. Naah, Lym-2 is better than Rituxan anyway. Not enough attention has been paid to this;(http://www.techniclone.com/pr102397.htm}. What about some kind of prelicensing deal with Coulter? Oncolym and Bexxar would lock up radiolabled treatment of NHL and Lym-2 could be cocktailed into all three grades. What a gift-wrapped package for a Bristol-Myers-Squibb or someone. What a massive license that would command!
Just speculating, of course. Any ideas Shero, Dave, John, anyone? Alys, Manfred where are you?
I'm on a friend's computer (I'm on borrowed time?) but I'll be checking in this weekend. Reasonable questions and speculations are welcome, that's what this forum is for. |
